Alpha-9 Oncology
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
185 Dartmouth St Ste 6, Boston, Massachu...Phone Number
(617) 865-1004Website
www.a9oncology.comRevenue
<$5 MillionIndustry
About Alpha-9 Oncology
Alpha-9 Oncology is a clinical-stage radiopharmaceutical company specializing in the development of highly selective and potent radiopharmaceuticals for cancer therapy. The company employs a bespoke, iterative design process to create targeted molecules that treat cancer cells with precision. With a leadership team experienced in oncology drug development, Alpha-9 is backed by top-tier investors and is committed to advancing cancer care through innovative precision medicine. Their portfolio includes advanced radiotherapeutics, such as A9-3408, which is currently in Phase 1 studies.Explore more
Alpha-9 Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Alpha-9 Oncology
Compare insights from companies similar to Alpha-9 Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Alpha-9 Oncology Tech Stack
A closer look at the technologies used by Alpha-9 Oncology
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alpha-9 Oncology
Sign Up For FreeTo access detailed company insights
Alpha-9 Oncology is a clinical-stage radiopharmaceutical company specializing in the development of highly selective and potent radiopharmaceuticals for cancer therapy. The company employs a bespoke, iterative design process to create targeted molecules that treat cancer cells with precision. With a leadership team experienced in oncology drug deve... Read More
